PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Down 44.9% in June

PMGC Holdings Inc. (NASDAQ:ELAB) saw a significant drop in short interest in the month of June. As of June 30th, there was short interest totaling 331,075 shares, a drop of 44.9% from the June 15th total of 601,191 shares. Approximately 28.6% of the company’s stock are short sold. Based on an average daily trading volume, of 387,077 shares, the days-to-cover ratio is presently 0.9 days.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a report on Friday, June 26th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

PMGC Stock Up 0.9%

PMGC stock traded up $0.01 during trading hours on Thursday, reaching $1.09. The stock had a trading volume of 1,288,974 shares, compared to its average volume of 4,802,460. The company has a market cap of $1.26 million, a price-to-earnings ratio of -0.01 and a beta of -0.23. The business’s 50 day moving average price is $1.52 and its 200-day moving average price is $8.17. PMGC has a 52 week low of $1.02 and a 52 week high of $309.12. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.45 and a quick ratio of 1.43.

PMGC (NASDAQ:ELAB) last released its quarterly earnings results on Thursday, May 14th. The company reported ($11.22) earnings per share for the quarter. The firm had revenue of $0.68 million for the quarter.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.